Pharmacy Joe

FEBRUARY 11, 2024

In this episode, I’ll discuss why glucagon is not recommended in the calcium channel blocker poisoning guidelines. Episode 895: Why is glucagon not recommended in the calcium channel blocker poisoning guidelines? Subscribe on iTunes , Android , or Stitcher Critical Care Medicine has published in 2017 Experts Consensus Recommendations for the Management of Calcium Channel Blocker Poisoning in Adults.

Hospitals 97

Hospitals Inpatient 97

Express Pharma

FEBRUARY 11, 2024

In January 2024, the healthcare industry reported 88 deals worth $13.8 billion, compared to the last 12-month average (January 2023 to December 2023) of 85 deals worth $19.3 billion. Deal Date Acquirer (s) Target Deal Value ($M) 8-Jan-24 Boston Scientific Corp (US) Axonics Inc (US) 3,700.0 8-Jan-24 Johnson & Johnson (US) Ambrx Biopharma Inc (US) 2,000.0 23-Jan-24 Sanofi (France) Inhibrx Inc (US) 1,700.0 9-Jan-24 GSK plc (United Kingdom) Aiolos Bio Inc (US) 1,400.0 8-Jan-24 Merck KGaA (German

Diabetes 93

Diabetes 93

pharmaphorum

FEBRUARY 11, 2024

MHRA license change means people in GB will be able to buy Pfizer’s COVID-19 vaccine Comirnaty at retail pharmacies from March

Vaccines 107

Vaccines 107

Express Pharma

FEBRUARY 11, 2024

Sun Pharmaceutical Industries has been included in the S&P Global Sustainability Yearbook 2024. Within respective industries, this Yearbook aims to distinguish those companies that have demonstrated strengths in corporate sustainability. A company statement informed, “This recognition attests to Sun Pharma’s commitment to incorporate Environmental, Social, and Governance (ESG) principles through focused initiatives across its businesses.

92

92

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

Drug Patent Watch

FEBRUARY 11, 2024

This chart shows the drugs with the most patents in Peru. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.… The post Which pharmaceutical drugs have the most drug patents in Peru? appeared first on DrugPatentWatch - Make Better Decisions.

59

59

Pharmacy Joe

FEBRUARY 11, 2024

In this episode, I’ll discuss why glucagon is not recommended in the calcium channel blocker poisoning guidelines. Episode 895: Why is glucagon not recommended in the calcium channel blocker poisoning guidelines? Subscribe on iTunes , Android , or Stitcher Critical Care Medicine has published in 2017 Experts Consensus Recommendations for the Management of Calcium Channel Blocker Poisoning in Adults.

Hospitals 52

Hospitals Inpatient 52

Med Ed 101

FEBRUARY 11, 2024

With many insulin formulations on the market, it can be hard to differentiate between similar-acting products and what the best choice may be for our patients. One question raised is what the differences between Novolog versus Fiasp are due to both being insulin aspart formulations. The main difference is right in the name of Fiasp. […] The post Novolog Versus Fiasp Insulin Comparison appeared first on Med Ed 101.

Diabetes 52

Diabetes 52

PharmaTech

FEBRUARY 11, 2024

Webinar Date/Time: Tue, Mar 5, 2024 2:00 PM EST

52

52

FDA Law Blog: Biosimilars

FEBRUARY 11, 2024

By Larry K. Houck — With apologies to David Letterman, who introduced the first Top Ten List on Late Night with David Letterman on September 18, 1985, we present “Marijuana: Top Ten Reasons for Descheduling, Rescheduling or Not.”* The wide range of assertions supporting or opposing Health and Human Services’ (“HHS’”) recommendation that the Drug Enforcement Administration (“DEA”) reschedule cannabis federally from schedule I to schedule III would lead an outsider to conclude that commenters are

Controlled Substances 57

Controlled Substances Chemotherapy Compounding 57